WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 4,049 shares were traded during trading, an increase of 85% from the previous session’s volume of 2,186 shares.The stock last traded at $24.74 and had previously closed at $24.98.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, WuXi AppTec currently has an average rating of “Moderate Buy”.
Read Our Latest Report on WUXAY
WuXi AppTec Stock Up 0.9%
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Featured Articles
- Five stocks we like better than WuXi AppTec
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
- 5 Stocks the Market Rewarded After Strong Earnings Results
- Is Wingstop’s Growth Story Losing Steam?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
